China Bronchodilators Market Report & Forecast 2021-2027

Publisher Name :
Date: 21-Dec-2021
No. of pages: 94
Inquire Before Buying

China Bronchodilators Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)

China Bronchodilators Market Segment Percentages, By Type, 2020 (%)

- Anticholinergic Bronchodilators

- Adrenergic Bronchodilators

- Bronchodilator Combinations

- Methylxanthines

China Bronchodilators Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)

China Bronchodilators Market Segment Percentages, By Application, 2020 (%)

- Asthma

- COPD

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bronchodilators revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Bronchodilators revenues share in China market, 2020 (%)

Key companies Bronchodilators sales in China market, 2016-2021 (Estimated), (K MT)

Key companies Bronchodilators sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- AstraZeneca

- Boehringer Ingelheim

- GlaxoSmithKline

- F. Hoffmann-La Roche

China Bronchodilators Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Bronchodilators Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Bronchodilators Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Bronchodilators Overall Market Size
2.1 China Bronchodilators Market Size: 2021 VS 2027
2.2 China Bronchodilators Revenue, Prospects & Forecasts: 2016-2027
2.3 China Bronchodilators Sales: 2016-2027
3 Company Landscape
3.1 Top Bronchodilators Players in China Market
3.2 Top China Bronchodilators Companies Ranked by Revenue
3.3 China Bronchodilators Revenue by Companies
3.4 China Bronchodilators Sales by Companies
3.5 China Bronchodilators Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Bronchodilators Companies in China Market, by Revenue in 2020
3.7 Manufacturers Bronchodilators Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bronchodilators Players in China Market
3.8.1 List of Tier 1 Bronchodilators Companies in China
3.8.2 List of Tier 2 and Tier 3 Bronchodilators Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Bronchodilators Market Size Markets, 2021 & 2027
4.1.2 Anticholinergic Bronchodilators
4.1.3 Adrenergic Bronchodilators
4.1.4 Bronchodilator Combinations
4.1.5 Methylxanthines
4.2 By Type - China Bronchodilators Revenue & Forecasts
4.2.1 By Type - China Bronchodilators Revenue, 2016-2021
4.2.2 By Type - China Bronchodilators Revenue, 2022-2027
4.2.3 By Type - China Bronchodilators Revenue Market Share, 2016-2027
4.3 By Type - China Bronchodilators Sales & Forecasts
4.3.1 By Type - China Bronchodilators Sales, 2016-2021
4.3.2 By Type - China Bronchodilators Sales, 2022-2027
4.3.3 By Type - China Bronchodilators Sales Market Share, 2016-2027
4.4 By Type - China Bronchodilators Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Bronchodilators Market Size, 2021 & 2027
5.1.2 Asthma
5.1.3 COPD
5.1.4 Others
5.2 By Application - China Bronchodilators Revenue & Forecasts
5.2.1 By Application - China Bronchodilators Revenue, 2016-2021
5.2.2 By Application - China Bronchodilators Revenue, 2022-2027
5.2.3 By Application - China Bronchodilators Revenue Market Share, 2016-2027
5.3 By Application - China Bronchodilators Sales & Forecasts
5.3.1 By Application - China Bronchodilators Sales, 2016-2021
5.3.2 By Application - China Bronchodilators Sales, 2022-2027
5.3.3 By Application - China Bronchodilators Sales Market Share, 2016-2027
5.4 By Application - China Bronchodilators Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Overview
6.1.3 AstraZeneca Bronchodilators Sales and Revenue in China Market (2016-2021)
6.1.4 AstraZeneca Bronchodilators Product Description
6.1.5 AstraZeneca Recent Developments
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Overview
6.2.3 Boehringer Ingelheim Bronchodilators Sales and Revenue in China Market (2016-2021)
6.2.4 Boehringer Ingelheim Bronchodilators Product Description
6.2.5 Boehringer Ingelheim Recent Developments
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Overview
6.3.3 GlaxoSmithKline Bronchodilators Sales and Revenue in China Market (2016-2021)
6.3.4 GlaxoSmithKline Bronchodilators Product Description
6.3.5 GlaxoSmithKline Recent Developments
6.4 F. Hoffmann-La Roche
6.4.1 F. Hoffmann-La Roche Corporation Information
6.4.2 F. Hoffmann-La Roche Overview
6.4.3 F. Hoffmann-La Roche Bronchodilators Sales and Revenue in China Market (2016-2021)
6.4.4 F. Hoffmann-La Roche Bronchodilators Product Description
6.4.5 F. Hoffmann-La Roche Recent Developments
7 China Bronchodilators Production Capacity, Analysis
7.1 China Bronchodilators Production Capacity, 2016-2027
7.2 Bronchodilators Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Bronchodilators Supply Chain Analysis
9.1 Bronchodilators Industry Value Chain
9.2 Bronchodilators Upstream Market
9.3 Bronchodilators Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Bronchodilators Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Bronchodilators in China Market
Table 2. Top Bronchodilators Players in China Market, Ranking by Revenue (2019)
Table 3. China Bronchodilators Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Bronchodilators Revenue Share by Companies, 2016-2021
Table 5. China Bronchodilators Sales by Companies, (K MT), 2016-2021
Table 6. China Bronchodilators Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Bronchodilators Price (2016-2021) & (USD/MT)
Table 8. Manufacturers Bronchodilators Product Type
Table 9. List of Tier 1 Bronchodilators Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Bronchodilators Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Anticholinergic Bronchodilators
Table 12. Major Manufacturers of Adrenergic Bronchodilators
Table 13. By Type - China Bronchodilators Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Bronchodilators Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Bronchodilators Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Bronchodilators Sales (K MT), 2016-2021
Table 17. By Type - China Bronchodilators Sales (K MT), 2022-2027
Table 18. By Application - China Bronchodilators Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Bronchodilators Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Bronchodilators Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Bronchodilators Sales (K MT), 2016-2021
Table 22. By Application - China Bronchodilators Sales (K MT), 2022-2027
Table 23. AstraZeneca Corporation Information
Table 24. AstraZeneca Description and Major Businesses
Table 25. AstraZeneca Bronchodilators Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 26. AstraZeneca Bronchodilators Product
Table 27. AstraZeneca Recent Developments
Table 28. Boehringer Ingelheim Corporation Information
Table 29. Boehringer Ingelheim Description and Major Businesses
Table 30. Boehringer Ingelheim Bronchodilators Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 31. Boehringer Ingelheim Bronchodilators Product
Table 32. Boehringer Ingelheim Recent Developments
Table 33. GlaxoSmithKline Corporation Information
Table 34. GlaxoSmithKline Description and Major Businesses
Table 35. GlaxoSmithKline Bronchodilators Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 36. GlaxoSmithKline Bronchodilators Product
Table 37. GlaxoSmithKline Recent Developments
Table 38. F. Hoffmann-La Roche Corporation Information
Table 39. F. Hoffmann-La Roche Description and Major Businesses
Table 40. F. Hoffmann-La Roche Bronchodilators Sales (K MT), Revenue (US$, Mn) and Gross Margin (USD/MT) (2016-2021)
Table 41. F. Hoffmann-La Roche Bronchodilators Product
Table 42. F. Hoffmann-La Roche Recent Developments
Table 43. Bronchodilators Production Capacity (K MT) of Key Manufacturers in China Market, 2019-2021 (K MT)
Table 44. China Bronchodilators Capacity Market Share of Key Manufacturers, 2019-2021
Table 45. Bronchodilators Market Opportunities & Trends in China Market
Table 46. Bronchodilators Market Drivers in China Market
Table 47. Bronchodilators Market Restraints in China Market
Table 48. Bronchodilators Raw Materials
Table 49. Bronchodilators Raw Materials Suppliers in China Market
Table 50. Typical Bronchodilators Downstream
Table 51. Bronchodilators Downstream Clients in China Market
Table 52. Bronchodilators Distributors and Sales Agents in China Market
List of Figures
Figure 1. Bronchodilators Product Picture
Figure 2. Bronchodilators Segment by Type
Figure 3. Bronchodilators Segment by Application
Figure 4. China Bronchodilators Market Overview: 2020
Figure 5. China Bronchodilators Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Bronchodilators Revenue, 2016-2027 (US$, Mn)
Figure 7. Bronchodilators Sales in China Market: 2016-2027 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Bronchodilators Revenue in 2020
Figure 9. Anticholinergic Bronchodilators Product Picture
Figure 10. Adrenergic Bronchodilators Product Picture
Figure 11. Bronchodilator Combinations Product Picture
Figure 12. Methylxanthines Product Picture
Figure 13. By Type - China Bronchodilators Sales Market Share, 2016-2027
Figure 14. By Type - China Bronchodilators Revenue Market Share, 2016-2027
Figure 15. By Type - China Bronchodilators Price (USD/MT), 2016-2027
Figure 16. Asthma
Figure 17. COPD
Figure 18. Others
Figure 19. By Application - China Bronchodilators Sales Market Share, 2016-2027
Figure 20. By Application - China Bronchodilators Revenue Market Share, 2016-2027
Figure 21. By Application - China Bronchodilators Price (USD/MT), 2016-2027
Figure 22. AstraZeneca Bronchodilators Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Boehringer Ingelheim Bronchodilators Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. GlaxoSmithKline Bronchodilators Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. F. Hoffmann-La Roche Bronchodilators Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. China Bronchodilators Production Capacity (K MT), 2016-2027
Figure 27. Bronchodilators Industry Value Chain
Figure 28. Marketing Channels
  • Global Montelukast Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Montelukast Sodium market size was valued at US$ 336.3 million in 2023. With growing demand in downstream market, the Montelukast Sodium is forecast to a readjusted size of US$ 815.4 million by 2030 with a CAGR of 13.5% during review period. The research report highlights the growth potential of the global Montelukast Sodium market. Montelukast Sodium are expected to show stable growth in the future market. However, product d......
  • Global Montelukast Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 132
    According to our (Global Info Research) latest study, the global Montelukast Sodium market size was valued at USD 353.8 million in 2023 and is forecast to a readjusted size of USD 803.8 million by 2030 with a CAGR of 12.4% during review period. Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chr......
  • Asthma Therapeutics - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 114
    The global Asthma Therapeutics market size is expected to reach US$ 27800 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Asthma Therapeutics in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Asthma Therapeutics market. Inhalation, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......
  • Global Asthma Therapeutics Market Research Report 2023, Forecast to 2028
    Published: 15-Dec-2023        Price: US 2680 Onwards        Pages: 163
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Budesonide Aerosol Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 146
    Report Overview: The Global Budesonide Aerosol Market Size was estimated at USD 7996.70 million in 2022 and is projected to reach USD 41912.84 million by 2029, exhibiting a CAGR of 26.70% during the forecast period. This report provides a deep insight into the global Budesonide Aerosol market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key marke......
  • Global Asthma Therapeutics Professional Survey Report 2023, Forecast to 2028
    Published: 15-Dec-2023        Price: US 3280 Onwards        Pages: 139
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Montelukast Sodium Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 144
    Report Overview: Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis. The Global Montelukast Sodium Market Size was estimated at USD 816.70 million in 2022 and is projected to reach USD 1921.37 million by 20......
  • Global Doxofylline (API) Market Research Report 2023
    Published: 28-Nov-2023        Price: US 2900 Onwards        Pages: 88
    Doxofylline (also known as doxophylline) is a phosphodiesterase inhibiting bronchodilator used in The treatment of chronic respiratory diseases such as asthma and COPD. Like theophylline, it is a xanthine derivative. According to QYResearch's new survey, global Doxofylline (API) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with The CAGR of % during The period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Uk......
  • Global Montelukast Sodium Market Research Report 2023, Forecast to 2028
    Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 164
    Montelukast sodium is an organic sodium salt. Montelukast is an orally available leukotriene receptor antagonist which is widely used for the prophylaxis and chronic treatment of asthma and has been linked to rare cases of clinically apparent liver injury. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs